Erasca IPOs on Nasdaq

Share on facebook
Share on twitter
Share on linkedin

Erasca IPOs on Nasdaq

EDBI has been part of Erasca’s journey since our investment in 2020, and celebrates with the team as their IPO bolsters the company’s war chest and accelerates development of their comprehensive suite of drugs targeting the Ras/MAPK pathway, furthering their mission of erasing cancer.

 

Read Erasca’s press release here: